Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MedImmune and Cerus to codevelop novel therapeutic vaccine

April 23, 2004

BTG licenses abiraterone acetate rights to Cougar

April 23, 2004

Improved pharmacokinetics, antitumor activity and tolerability for liposomal vinorelbine

April 23, 2004

Novel Raf kinase inhibitors under study at Merck KGaA

April 23, 2004

In vitro, in vivo and pharmacodynamic evaluations of Flt-3/KDR inhibitor

April 23, 2004

Genasense available through Expanded Access Program for advanced melanoma

April 22, 2004

Bristol-Myers Squibb receives North American and Asian license for Javlor

April 22, 2004

CT-2106 enters phase I/II trial for colorectal cancer

April 22, 2004

Orphan medicinal product status for CA4P for anaplastic thyroid cancer

April 22, 2004

Three series of telomerase inhibitors described by researchers at Mitsui Chemicals

April 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...